Cord Blood America (CBAI) 0.0034 $CBAI
Cord Blood America Reports 2016 First Quarter Financial Results
ACCESSWIRE - Mon May 16, 8:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / May 16, 2016 / Cord Blood America, Inc. (http://www.cordblood-america.com/) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
today announced financial results for the first quarter ended March 31, 2016.
Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2015
ACCESSWIRE - Wed Mar 30, 8:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / March 30, 2016 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company" today announced financial results for the fourth quarter and fiscal year 2015.
Cord Blood America, Inc. Announces Strategic Update
ACCESSWIRE - Fri Feb 19, 8:30AM CST
LAS VEGAS, NV / ACCESSWIRE / February 19, 2016 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company" today announced that the Board has approved the engagement of Boxwood Partners, LLC to advise the Company in its review of strategic alternatives. Coincident with this engagement - which follows a recent outsourcing of many lab functions - Joseph Vicente and the Company have reached a mutual agreement pursuant to which Mr. Vicente stepped down as President and as a Director of the Company effective at the close of business on February 12, 2016. The Company's Board of Directors has named Stephen Morgan, Vice President and General Counsel, as interim President, in his place.
CBAI Announces Review of Strategic Alternatives
ACCESSWIRE - Thu Dec 10, 9:30AM CST
LAS VEGAS, NV / ACCESSWIRE / December 10, 2015 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company" today announced that its Board of Directors (the "Board" has unanimously determined to undertake a review of strategic alternatives available to the Company, which may include a possible sale of assets or the sale of the Company, along with other alternatives or forms of business combination. The review of any alternatives would be evaluated against the Company's progress as a standalone business as it continues to execute or considers a change in its strategic business plan.
Cord Blood America Reports 2015 Third Quarter Financial Results
ACCESSWIRE - Mon Nov 16, 7:00AM CST
Revenue increased 19%, EBITDA of $0.33 million
Cord Blood America swings to net income of USD0.40m for Q2 2015
M2 - Mon Aug 17, 5:57AM CDT
Cord Blood America (OTC BB:CBAI) disclosed on Friday that its net income was USD0.40m for the second quarter ended 30 June 2015.
Cord Blood America Reports 2015 Second Quarter Financial Results
PR Newswire - Fri Aug 14, 7:30AM CDT
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company" today announced financial results for the second quarter ended June 30, 2015.
Global Market Study on UCB Banking 2015: Asia-Pacific to Witness Highest Growth by 2020
M2 - Wed Jul 08, 4:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7m2q2/global_market) has announced the addition of the "Global Market Study on UCB Banking: Asia-Pacific to Witness Highest Growth by 2020" report to their offering. The global UCB banking market was valued at 10,900 million in 2010 and it expanded to USD 12,774.8 million in 2013. North America has the largest market share, followed by Europe and Asia-Pacific, in the global UCB banking market. Globally, increasing prevalence of chronic diseases coupled with the emerging field of regenerative medicines is driving the UCB banking market. In addition, various government associations and initiatives are also supporting in the growth of the UCB banking market. North America has the largest market for UCB banking. The U.S., followed by Canada, is the largest market for UCB banking in the region. Increasing prevalence of chronic diseases is the key driver of the UCB banking market. In addition, initiatives by various government associations have also led to the increase in awareness about the importance of cord blood donation in the region. In Europe, the UCB banking market is growing due to increased awareness about potential applications of cord blood in the treatment of life-threatening diseases. In addition, increasing number of live births is also playing a vital role in the growth of UCB banking market in Europe. For instance, according to Eurostat, in 2010, 807,271 live births registered in 2010 and the number reached to 812,970 by 2013 in the U.K.. Due to increased awareness about potential of cord blood, newborns family donates and preserves cord blood either in private or public banks in Europe. However, Asia-Pacific is the fastest growing region in the UCB banking market. This is due to increasing prevalence of chronic diseases in the region. In addition, raising awareness about potential applications of cord blood and increasing number of live births are also contributing in the growth of UCB banking market in the region. China has the highest number of live births, followed by India around the world. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Therapeutic Application of UCB Chapter 7 Market Size and Forecast by Storage Option Chapter 8 Market Size and Forecast by Geography Chapter 9 Competitive Scenario Chapter 10 Company Profiles - China Cord Blood Corporation - Cord Blood America, Inc. - Cord Blood Registry Systems, Inc. - Cordlife Group Limited - Cryo-Cell International, Inc. - Esperite N.V. - NeoStem, Inc. - Smart Cells International, Ltd. - StemCyte - ViaCord For more information visit http://www.researchandmarkets.com/research/c7...bal_market
NBS: 2.25 (-0.09), CO: 5.99 (-0.09)
Cord Blood America Reports 2015 First Quarter Financial Results and Results of Special Shareholder Meeting, Announces Annual General Meeting
PR Newswire - Fri May 08, 7:30AM CDT
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company" today announced financial results for the quarter ended March 31, 2015 and the results of the Special Shareholder Meeting.
Cord Blood America signs equity investment agreement with Red Oak Partners
M2 - Mon Apr 13, 6:43AM CDT
Cord blood stem cells company Cord Blood America (OTC BB:CBAI) on Friday reported a purchase agreement for the sale of USD0.724m preferred equity investment funded by Red Oak Partners and its affiliates (Red Oak).
Cord Blood America Announces 2014 Full Year Financial Results
PR Newswire - Tue Mar 31, 7:45AM CDT
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company" today announced financial results for the year ended December 31, 2014.
Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested
PR Newswire - Fri Jan 23, 7:00AM CST
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company" filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange Commission (www.sec.gov) today, and provides an update for shareholders detailing why a "YES" vote to increase the number of authorized shares is requested.
Cord Blood America Announces 2014 Third Quarter Financial Results
PR Newswire - Fri Nov 14, 7:45AM CST
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company" today announced financial results for the third quarter ended September 30, 2014.
Cord Blood America sells holdings in Biocordcell Argentina SA
M2 - Mon Oct 06, 7:15AM CDT
Umbilical cord blood company Cord Blood America (OTC BB:CBAI) disclosed on Friday the sale of its ownership stake in Biocordcell Argentina SA (Bio) to Diego Rissola.
Cord Blood America Reports 2016 First Quarter Financial Results
ACCESSWIRE - Mon May 16, 8:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / May 16, 2016 / Cord Blood America, Inc. (http://www.cordblood-america.com/) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
today announced financial results for the first quarter ended March 31, 2016. Cord Blood America Reports Financial Results for Fourth Quarter and Fiscal Year 2015
ACCESSWIRE - Wed Mar 30, 8:00AM CDT
LAS VEGAS, NV / ACCESSWIRE / March 30, 2016 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company"
today announced financial results for the fourth quarter and fiscal year 2015. Cord Blood America, Inc. Announces Strategic Update
ACCESSWIRE - Fri Feb 19, 8:30AM CST
LAS VEGAS, NV / ACCESSWIRE / February 19, 2016 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company"
today announced that the Board has approved the engagement of Boxwood Partners, LLC to advise the Company in its review of strategic alternatives. Coincident with this engagement - which follows a recent outsourcing of many lab functions - Joseph Vicente and the Company have reached a mutual agreement pursuant to which Mr. Vicente stepped down as President and as a Director of the Company effective at the close of business on February 12, 2016. The Company's Board of Directors has named Stephen Morgan, Vice President and General Counsel, as interim President, in his place. CBAI Announces Review of Strategic Alternatives
ACCESSWIRE - Thu Dec 10, 9:30AM CST
LAS VEGAS, NV / ACCESSWIRE / December 10, 2015 / Cord Blood America, Inc. (www.cordblood-america.com) (OTC: CBAI) ("CBAI" or the "Company"
today announced that its Board of Directors (the "Board" has unanimously determined to undertake a review of strategic alternatives available to the Company, which may include a possible sale of assets or the sale of the Company, along with other alternatives or forms of business combination. The review of any alternatives would be evaluated against the Company's progress as a standalone business as it continues to execute or considers a change in its strategic business plan. Cord Blood America Reports 2015 Third Quarter Financial Results
ACCESSWIRE - Mon Nov 16, 7:00AM CST
Revenue increased 19%, EBITDA of $0.33 million
Cord Blood America swings to net income of USD0.40m for Q2 2015
M2 - Mon Aug 17, 5:57AM CDT
Cord Blood America (OTC BB:CBAI) disclosed on Friday that its net income was USD0.40m for the second quarter ended 30 June 2015.
Cord Blood America Reports 2015 Second Quarter Financial Results
PR Newswire - Fri Aug 14, 7:30AM CDT
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
today announced financial results for the second quarter ended June 30, 2015. Global Market Study on UCB Banking 2015: Asia-Pacific to Witness Highest Growth by 2020
M2 - Wed Jul 08, 4:34AM CDT
Research and Markets (http://www.researchandmarkets.com/research/c7m2q2/global_market) has announced the addition of the "Global Market Study on UCB Banking: Asia-Pacific to Witness Highest Growth by 2020" report to their offering. The global UCB banking market was valued at 10,900 million in 2010 and it expanded to USD 12,774.8 million in 2013. North America has the largest market share, followed by Europe and Asia-Pacific, in the global UCB banking market. Globally, increasing prevalence of chronic diseases coupled with the emerging field of regenerative medicines is driving the UCB banking market. In addition, various government associations and initiatives are also supporting in the growth of the UCB banking market. North America has the largest market for UCB banking. The U.S., followed by Canada, is the largest market for UCB banking in the region. Increasing prevalence of chronic diseases is the key driver of the UCB banking market. In addition, initiatives by various government associations have also led to the increase in awareness about the importance of cord blood donation in the region. In Europe, the UCB banking market is growing due to increased awareness about potential applications of cord blood in the treatment of life-threatening diseases. In addition, increasing number of live births is also playing a vital role in the growth of UCB banking market in Europe. For instance, according to Eurostat, in 2010, 807,271 live births registered in 2010 and the number reached to 812,970 by 2013 in the U.K.. Due to increased awareness about potential of cord blood, newborns family donates and preserves cord blood either in private or public banks in Europe. However, Asia-Pacific is the fastest growing region in the UCB banking market. This is due to increasing prevalence of chronic diseases in the region. In addition, raising awareness about potential applications of cord blood and increasing number of live births are also contributing in the growth of UCB banking market in the region. China has the highest number of live births, followed by India around the world. Key Topics Covered: Chapter 1 Preface Chapter 2 Market Synopsis Chapter 3 Porter's Five Forces Analysis Chapter 4 Industry overview Chapter 5 Global Market Size and Forecast Chapter 6 Market Size and Forecast by Therapeutic Application of UCB Chapter 7 Market Size and Forecast by Storage Option Chapter 8 Market Size and Forecast by Geography Chapter 9 Competitive Scenario Chapter 10 Company Profiles - China Cord Blood Corporation - Cord Blood America, Inc. - Cord Blood Registry Systems, Inc. - Cordlife Group Limited - Cryo-Cell International, Inc. - Esperite N.V. - NeoStem, Inc. - Smart Cells International, Ltd. - StemCyte - ViaCord For more information visit http://www.researchandmarkets.com/research/c7...bal_market
NBS: 2.25 (-0.09), CO: 5.99 (-0.09)
Cord Blood America Reports 2015 First Quarter Financial Results and Results of Special Shareholder Meeting, Announces Annual General Meeting
PR Newswire - Fri May 08, 7:30AM CDT
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
today announced financial results for the quarter ended March 31, 2015 and the results of the Special Shareholder Meeting. Cord Blood America signs equity investment agreement with Red Oak Partners
M2 - Mon Apr 13, 6:43AM CDT
Cord blood stem cells company Cord Blood America (OTC BB:CBAI) on Friday reported a purchase agreement for the sale of USD0.724m preferred equity investment funded by Red Oak Partners and its affiliates (Red Oak).
Cord Blood America Announces 2014 Full Year Financial Results
PR Newswire - Tue Mar 31, 7:45AM CDT
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
today announced financial results for the year ended December 31, 2014. Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested
PR Newswire - Fri Jan 23, 7:00AM CST
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & Exchange Commission (www.sec.gov) today, and provides an update for shareholders detailing why a "YES" vote to increase the number of authorized shares is requested. Cord Blood America Announces 2014 Third Quarter Financial Results
PR Newswire - Fri Nov 14, 7:45AM CST
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI) ("CBAI" or the "Company"
today announced financial results for the third quarter ended September 30, 2014. Cord Blood America sells holdings in Biocordcell Argentina SA
M2 - Mon Oct 06, 7:15AM CDT
Umbilical cord blood company Cord Blood America (OTC BB:CBAI) disclosed on Friday the sale of its ownership stake in Biocordcell Argentina SA (Bio) to Diego Rissola.
